SANOFI U.S.

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2019–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	4	1
2024	—	4	1
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	4	1
2019	—	5	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
FORBES-TATE	—	32

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	31
SENATE	31

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	32
Medicare/Medicaid	Medicare/Medicaid	32
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	20
Trade (domestic/foreign)	Trade (domestic/foreign)	6
Defense	Defense	4
Budget/Appropriations	Budget/Appropriations	2

Bills Explicitly Cited (21)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2023 · second_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug pricing, including the implementation of H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to 340B.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2023 · second_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug pricing; Issues related to Section 340B of the Public Health Service Act; Drug pricing Issues Related to implementation of H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to flu vaccines.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2023 · first_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug pricing; Issues related to Section 340B of the Public Health Service Act; Drug pricing Issues Related to implementation of H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to flu vaccines.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2023 · first_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug pricing, including the implementation of H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to 340B.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 5376

Show 17 more cited filings

H.R. 2471117th Congress

Consolidated Appropriations Act, 2022

2022 · fourth_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug pricing; Issues related to Section 340B of the Public Health Service Act; Issues related to H.R.5376 - Build Back Better Act; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022; Drug pricing Issues Related to H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169).

Client expense: — · Firm income: $50,000

Matched citations: H.R.2471

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · fourth_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug pricing; Issues related to Section 340B of the Public Health Service Act; Issues related to H.R.5376 - Build Back Better Act; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022; Drug pricing Issues Related to H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169).

Client expense: — · Firm income: $50,000

Matched citations: H.R. 5376, H.R.5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · fourth_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to orphan drug tax credit; Issues related to H.R.5376 - Build Back Better Act; Issues related to the excise tax for the Vaccine Injury Compensation Fund.

Client expense: — · Firm income: $50,000

Matched citations: H.R.5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · fourth_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug pricing, including the H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to 340B.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 5376

H.R. 2471117th Congress

Consolidated Appropriations Act, 2022

2022 · third_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug pricing; Issues related to Section 340B of the Public Health Service Act; Issues related to H.R.5376 - Build Back Better Act; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022; Drug pricing Issues Related to H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169).

Client expense: — · Firm income: $50,000

Matched citations: H.R.2471

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · third_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug pricing, including the H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to 340B.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · third_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to orphan drug tax credit; Issues related to H.R.5376 - Build Back Better Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R.5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · third_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug pricing; Issues related to Section 340B of the Public Health Service Act; Issues related to H.R.5376 - Build Back Better Act; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022; Drug pricing Issues Related to H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169).

Client expense: — · Firm income: $50,000

Matched citations: H.R. 5376, H.R.5376

H.R. 2471117th Congress

Consolidated Appropriations Act, 2022

2022 · second_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug pricing; Issues related to Section 340B of the Public Health Service Act; Issues related to H.R.5376 - Build Back Better Act; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022; Issues related to the prescription drug user fee acts.

Client expense: — · Firm income: $50,000

Matched citations: H.R.2471

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · second_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to orphan drug tax credit; Issues related to H.R.5376 - Build Back Better Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R.5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · second_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug pricing; Issues related to Section 340B of the Public Health Service Act; Issues related to H.R.5376 - Build Back Better Act; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022; Issues related to the prescription drug user fee acts.

Client expense: — · Firm income: $50,000

Matched citations: H.R.5376

H.R. 2471117th Congress

Consolidated Appropriations Act, 2022

2022 · first_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug pricing; Issues related to Section 340B of the Public Health Service Act; Issues related to H.R.5376 - Build Back Better Act; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022.

Client expense: — · Firm income: $50,000

Matched citations: H.R.2471

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · first_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug pricing; Issues related to Section 340B of the Public Health Service Act; Issues related to H.R.5376 - Build Back Better Act; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022.

Client expense: — · Firm income: $50,000

Matched citations: H.R.5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · first_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to orphan drug tax credit; Issues related to H.R.5376 - Build Back Better Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R.5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2021 · fourth_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to orphan drug tax credit; Issues related to H.R.5376 - Build Back Better Act

Client expense: — · Firm income: $50,000

Matched citations: H.R.5376

H.R. 925116th Congress

The Heroes Act

2020 · fourth_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R. 925 - The Heroes Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 925

H.R. 925116th Congress

The Heroes Act

2020 · third_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R. 925 - The Heroes Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 925

Source: Senate LDA

SANOFI U.S. — Lobbying Disclosure | Poliscope